-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Downgrades NeuroSense Therapeutics to Hold

Benzinga·12/16/2024 15:27:51
Listen to the news
Maxim Group analyst Naz Rahman downgrades NeuroSense Therapeutics (NASDAQ:NRSN) from Buy to Hold.